SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb (40143-R019)

SARS-CoV-2 (2019-nCoV) Nucleocapsid抗体, Rabbit MAb

应用:WB, ELISA
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
WB1:1000-1:10000
ELISA1:5000-1:10000

应用说明

(Antibody's applications have not been validated with corresponding viruses. Optimal concentrations/dilutions should be determined by the end user.)

推荐稀释说明

Optimal concentrations/dilutions should be determined by the end user.

详细信息

免疫原Recombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
宿主/亚型Monoclonal Rabbit IgG Clone #019
抗体类型Monoclonal
产品类型Antibody
克隆号019
产品形式Liquid
偶联物Unconjugated
纯化方式Protein A
储存缓冲液0.2 μm filtered solution in PBS
储存条件This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
RRIDAB_2827973

特异性

SARS-CoV-2 Nucleocapsid SARS-CoV Nucleocapsid Has cross-reactivity in ELISA with SARS-CoV-2 Omicron (B.1.1.529) Nucleocapsid Protein (Cat #40588-V07E34) SARS-CoV-2 Omicron (BA.2) Nucleocapsid Protein (Cat# 40588-V07E35) SARS-CoV-2 Omicron XE(BA.1 x BA.2) Nucleocapsid Protein (Cat# 40588-V07E36) SARS-CoV-2 Omicron (BA.4) Nucleocapsid Protein (Cat# 40588-V07E37) SARS-CoV-2 Delta (B.1.617.2) Nucleocapsid Protein (Cat# 40588-V07E29) No cross-reactivity in ELISA with MERS-CoV Nucleocapsid protein (Cat# 40068-V08B) HCoV-229E Nucleocapsid protein (Cat# 40640-V07E) HCoV-NL63 Nucleocapsid protein (Cat# 40641-V07E) HCoV-HKU1(isolate N5) Nucleocapsid protein (Cat# 40642-V07E) HCoV-OC43 Nucleocapsid protein (Cat# 40643-V07E)

制备方法

This product is a recombinant monoclonal antibody expressed from HEK293 cells.

运输条件

This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

背景信息

Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. The coronavirus N protein is required for coronavirus RNA synthesis and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is the most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to the formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of the N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool. References 1.Van Boheemen S, et al. (2012), MBio. 3(6):e00473-12. Bisht H. et al., 2004, Proc Natl Acad Sci. 101 (17): 6641-6. Li W. et al., 2005, Science. 309 (5742): 1864-8.

文献引用 (105)

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

用于 SARS-CoV-2 感染的人类 ACE2 敲入小鼠模型重现了呼吸系统疾病,但避免了与转基因 K18-hACE2 模型相关的神经系统疾病

Pons-Grífols Anna, Tarrés-Freixas Ferran, Pérez Mònica, Riveira-Muñoz Eva, Raïch-Regué Dàlia, Perez-Zsolt Daniel, Muñoz-Basagoiti Jordana, Tondelli Barbara, Pradenas Edwards, Izquierdo-Useros Nuria, Capdevila Sara, Vergara-Alert Júlia, Urrea Victor, Carrillo Jorge, Ballana Ester, Forrow Stephen, Clotet Bonaventura, Segalés Joaquim, Trinité Benjamin, Blanco JuliÃ

Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2.

罂粟碱靶向 STAT 信号通路:对抗 SARS-CoV-2 的双重作用疗法选择

Reus Philipp, Torbica Emma, Rothenburger Tamara, Bechtel Marco, Kandler Joshua, Ciesek Sandra, Gribbon Philip, Kannt Aimo, Cinatl Jindrich, Bojkova Denisa

Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.

SARS-CoV-2 感染对仓鼠长期神经认知功能的影响

Ruiz-Casas Carla, Tarrés-Freixas Ferran, Roca Núria, Pérez Mònica, Cantero Guillermo, Martín Laura, Olvera Alex, Ruiz-Riol Marta, Brander Christian, Usai Carla, Vergara-Alert Júlia, Segalés Joaquim

An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters.

在糖基工程植物中产生的 ACE2-Fc 诱饵可以中和祖先和新出现的 SARS-CoV-2 变种,并在仓鼠身上证明了治疗效果

Föderl-Höbenreich Esther, Izadi Shiva, Hofacker Lara, Kienzl Nikolaus F, Castilho Alexandra, Strasser Richard, Tarrés-Freixas Ferran, Cantero Guillermo, Roca Núria, Pérez Mònica, Lorca-Oró Cristina, Usai Carla, Segalés Joaquim, Vergara-Alert Júlia, Mach Lukas, Zatloukal Kurt

Severe Acute Respiratory Syndrome Coronavirus 2 Variant Infection Dynamics and Pathogenesis in Transgenic K18-h ACE2 and Inbred Immunocompetent C57BL/6J Mice

严重急性呼吸综合征冠状病毒2变异株在转基因K18-h ACE2和近交系免疫功能正常C57BL/6J小鼠中的感染动力学和致病机制

Hongwei Liu ,Brianna M Ramirez ,Talia S Wong ,Christopher M Weiss ,Kevin C K Lloyd ,Qizhi Gong ,Lark L Coffey

The Virus Entry Pathway Determines Sensitivity to the Antiviral Peptide TAT-I24.

病毒进入途径决定了对TAT-I24抗病毒肽的敏感性

Kicker Eva, Kouros Antonio, Zatloukal Kurt, Harant Hanna

Genome-Wide Interrogation of SARS-CoV-2 RNA-Protein Interactions Uncovers Hidden Regulatory Sites.

对 SARS-CoV-2 RNA-蛋白质相互作用进行全基因组分析,揭示隐藏的调控位点

Xiang Joy S, Zhao Karen X, Tadri Laliv, Tamaru Kurt, Yee Brian A, Rothamel Katherine, Schmok Jonathan C, Mueller Jasmine R, Park Samuel S, Madrigal Assael A, McVicar Rachael N, Kwong Elizabeth M, Croker Ben A, Clark Alex E, Carlin Aaron F, Acevedo Charly, McCole Declan, O'Leary Seán E, Hai Rong, Leibel Sandra L, Yeo Gene W

SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation

SARS-CoV-2 异常提高线粒体生物能,从而诱导病毒强劲繁殖

Hye Jin Shin, Wooseong Lee, Keun Bon Ku, Gun Young Yoon, Hyun-Woo Moon, Chonsaeng Kim, Mi-Hwa Kim, Yoon-Sun Yi, Sangmi Jun, Bum-Tae Kim, Jong-Won Oh, Aleem Siddiqui, Seong-Jun Kim

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

既往感染或疫苗接种可赋予针对异源SARS-CoV-2攻击的非抗体依赖性保护作用。

Valeria Fumagalli ,Micol Ravà ,Davide Marotta ,Pietro Di Lucia ,Elisa B Bono ,Leonardo Giustini ,Federica De Leo ,Maura Casalgrandi ,Emanuele Monteleone ,Violette Mouro ,Chiara Malpighi ,Chiara Perucchini ,Marta Grillo ,Sara De Palma ,Lorena Donnici ,Silvia Marchese ,Matteo Conti ,Hiromi Muramatsu ,Stanley Perlman ,Norbert Pardi ,Mirela Kuka ,Raffaele De Francesco # ,Marco E Bianchi # ,Luca G Guidotti # ,Matteo Iannacone #

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality.

确定 FasL 是驱动 COVID-19 病理和致死性的关键宿主因素

Albert Marie-Christine, Uranga-Murillo Iratxe, Arias Maykel, De Miguel Diego, Peña Natacha, Montinaro Antonella, Varanda Ana Beatriz, Theobald Sebastian J, Areso Itziar, Saggau Julia, Koch Manuel, Liccardi Gianmaria, Peltzer Nieves, Rybniker Jan, Hurtado-Guerrero Ramón, Merino Pedro, Monzón Marta, Badiola Juan J, Reindl-Schwaighofer Roman, Sanz-Pamplona Rebeca, Cebollada-Solanas Alberto, Megyesfalvi Zsolt, Dome Balazs, Secrier Maria, Hartmann Boris, Bergmann Michael, Pardo Julián, Walczak Henning
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 11